Verastem (VSTM) Interest Expenses (2017 - 2026)
Verastem (VSTM) recorded quarterly Interest Expenses of $382000.0 in Q1 2026, down 7.95% quarter-over-quarter from $415000.0 in Q4 2025, and up 98.96% on a YoY basis from $192000.0 in Q1 2025.
Verastem (VSTM) Interest Expenses (2017 - 2026) Analysis & Trends
Verastem's Interest Expenses history runs 10 years deep, the most recent figure standing at $382000.0 for Q1 2026.
- In Q1 2026, Interest Expenses rose 98.96% year-over-year to $382000.0; the TTM figure through Mar 2026 stood at $1.2 million (down 66.45% YoY), while the FY2025 annual figure was $1.1 million, down 75.05% from the prior year.
- Interest Expenses was $382000.0 for Q1 2026 at Verastem, down from $415000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1.1 million in Q3 2024 to a low of $56000.0 in Q1 2022.
- Historically, Interest Expenses has averaged $720352.9 across 5 years, with a median of $724000.0 in 2022.
- Biggest YoY gain for Interest Expenses was 7140.0% in 2022; the steepest drop was 94.26% in 2022.
- A 5-year view of Interest Expenses shows it stood at $724000.0 in 2022, then jumped by 54.7% to $1.1 million in 2023, then grew by 2.32% to $1.1 million in 2024, then tumbled by 63.79% to $415000.0 in 2025, then declined by 7.95% to $382000.0 in 2026.
- The last three Interest Expenses figures came in at $382000.0 (Q1 2026), $415000.0 (Q4 2025), and $319000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 382,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 382,000.00 |
| Mar 31, 2026 | 382,000.00 |
| Dec 31, 2025 | 415,000.00 |
| Dec 31, 2025 | 415,000.00 |
| Sep 30, 2025 | 319,000.00 |
| Sep 30, 2025 | 319,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 1.15 Mn |
| Dec 31, 2024 | 1.15 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 1.12 Mn |
| Dec 31, 2023 | 1.12 Mn |